PARSIPPANY, N.J., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (NASDAQ: CAR) (the “Company”) announced today that its wholly-owned subsidiaries, Avis Budget Car Rental, LLC and Avis Budget Finance, Inc. (together, the “Issuers”), priced a private offering of $700 million aggregate principal amount of 8.250% senior notes due 2030 (the “Notes”), which represents a $200 million increase from the previously announced size of the offering. The Notes will have a maturity date of January 15, 2030. Th ...

NEWTOWN, Pa., Sept. 10, 2024 (GLOBE NEWSWIRE) -- The law firm of Edelson Lechtzin LLP is investigating claims regarding data privacy violations by Avis Rent A Car System LLC (“Avis”). Avis learned of suspicious activity on or about August 5, 2024. To join this case, go HERE. About Avis Rent a Car System LLC Avis is an American car rental company headquartered in Parsippany-Troy Hills, New Jersey. What happened? On or about August 5, 2024, Avis discovered that hackers had accessed one of their business appli ...

PARSIPPANY, N.J., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (NASDAQ: CAR) (the “Company”) announced today that its wholly-owned subsidiaries, Avis Budget Car Rental, LLC and Avis Budget Finance, Inc. (together, the “Issuers”), intend, subject to market and other customary conditions, to offer $500 million aggregate principal amount of senior notes due 2030 (the “Notes”) in a private offering. The Notes will be guaranteed on a senior unsecured basis by Avis Budget Group, Inc. and certain of ...

OKLAHOMA CITY, Okla., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Murphy Law Firm is investigating claims on behalf of all individuals whose personal and confidential information was compromised in the data breach involving Avis Rent A Car (“Avis”). To join the class action lawsuit, visit our site HERE. On August 5, 2024, Avis Rent A Car System, LLC (“Avis”) detected suspicious activity on its computer network, indicating a data breach. Based on a subsequent forensic investigation, Avis determined that cybercriminal ...

Car rental giant Avis is notifying hundreds of thousands of people that their personal information and driver’s license numbers were stolen in an August cyberattack.The New Jersey-headquartered company said in a data breach notice filed with several U.S. attorneys general over the past week that it discovered intruders in one of its business applications on August 5 and took efforts to end the unauthorized access, which the company said began two days earlier.  Avis did not disclose the nature of the cyber ...

Kaan Uluer/iStock via Getty Images Note: All amounts discussed are in Canadian Dollars. Stock Prices refer to those on the TSX and not the OTC symbol. In May of this year, we switched to a Buy on Canadian Apartment Properties Real Estate Investment Trust (TSX:CAR.UN:CA) (“CAPREIT”) and acquired a chunk of shares. The REIT was hit with the same malaise that infected the entire Canadian sector. But unlike some distressed names, this one had no real issues, apart from a lack of investor patience. That pat ...

Reactivation of P-BCMA-101 CAR-T cells and a repeat stringent complete response (sCR) more than 3 years after original CAR-T therapyDemonstrates potential of stem cell memory T cells (TSCM), a key differentiator for Poseida's CAR-T programs SAN DIEGO, Sept. 4, 2024 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage allogeneic cell therapy and genetic medicines company advancing differentiated non-viral treatments for patients with cancer and rare diseases, highlighted new data from ...

SAN JOSE, Calif., Sept. 3, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that the inventor of its ovarian cancer CAR-T technology, Jose R. Conejo-Garcia, M.D., Ph.D., Professor of Immunology in the Department of Integrative Immunobiology at the Duke University School of Medicine, will be speaking at the Rivkin Center and American Association for Cancer Research (AACR) 15th Bie ...

Descartes-15 observed to achieve an approximately ten-fold increase relative to Descartes-08 in CAR expression and selective target-specific killing in preclinical studies GAITHERSBURG, Md., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today announced that the first patient has been dosed in its first-in-human Phase 1 trial of Descartes-15, the Company’s next-genera ...

Rost-9D/iStock via Getty ImagesAllogene Therapeutics, Inc. (NASDAQ:ALLO) is a clinical-stage biotech company developing allogeneic chimeric antigen receptor T cell (AlloCAR T) therapies for cancer and autoimmune diseases. ALLO uses advanced gene-editing platforms like TALEN and CRISPR/Cas9 to engineer donor-derived T cells. These off-the-shelf treatments overcome the limitations of autologous therapies by targeting and killing malignant cells. The company’s robust pipeline covers hematologic malignancie ...